These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13892746)

  • 21. [Strophanthin K and P-aminobenzoate of diethylammonium in cardiotonic-sedative therapy].
    LAMBERTI F
    Gazz Med Ital; 1954 Sep; 113(9):272-7. PubMed ID: 13232215
    [No Abstract]   [Full Text] [Related]  

  • 22. [Practical experiences with heptamyl, a new cardiotonic substance].
    PEUKERT E
    Dtsch Med J; 1962 Jul; 13():420-3. PubMed ID: 14486063
    [No Abstract]   [Full Text] [Related]  

  • 23. [The treatment of endogenous depression with a new monoamine oxidase inhibitor].
    SATTES H; THIELE W
    Med Klin; 1962 Aug; 57():1458-60. PubMed ID: 14497477
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results obtained with a new monoamine oxidase inhibitor in the treatment of arterial hypertension].
    HOREAU J; NICOLAS G; ROBIN C; LABOUX L; GUENEL J
    Sem Hop; 1962 Mar; 38():848-52. PubMed ID: 14448875
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monoamine oxidase inhibitor in the treatment of angina pectoris].
    SCHWEIZER W
    Chemotherapia (Basel); 1962; 4():130-40. PubMed ID: 13909828
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative efficiency of strophanthin preparations in cardiac disease.
    GOTTSEGEN G
    Ther Hung; 1954; 3():15-8. PubMed ID: 13247268
    [No Abstract]   [Full Text] [Related]  

  • 27. ANTIANGINAL, VASOPRESSOR, CARDIOTONIC DRUGS--CURRENT STATUS AND RATIONAL.
    STEEL HH
    JAMA; 1964 Feb; 187():SUPPL 25-32. PubMed ID: 14089020
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative aspects of strophanthin activity].
    STORZ H
    Klin Wochenschr; 1958 Feb; 36(3):124-7. PubMed ID: 13540133
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experiences with monoamine oxidase inhibitor (niamid) in the treatment of hypertension].
    MORIMITSU M; KAGEURA K; IWASAKI S; YAMADA H; SUMIDA T; HUJIHARA T; HORITA S; HIGA M
    Nagasaki Igakkai Zasshi; 1962 Feb; 37():14-9. PubMed ID: 14476071
    [No Abstract]   [Full Text] [Related]  

  • 30. [Enzymatic inhibition and its therapeutic use in some dermatoses].
    CORTES JL; RADILLO S
    Medicina (Mex); 1961 Oct; 41():443-50. PubMed ID: 13881498
    [No Abstract]   [Full Text] [Related]  

  • 31. [The problem of strophanthin tolerance].
    SCHURMEYER A; WILLEMS H
    Medizinische; 1956 Sep; 1(35):1178-82. PubMed ID: 13369040
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of vascular headaches with nialamide, a monoamine oxidase inhibitor].
    MICHELACCI S; FRANCHI G
    Minerva Med; 1962 May; 53():1521-3. PubMed ID: 14473424
    [No Abstract]   [Full Text] [Related]  

  • 33. Diamox (acetazoleamide) as an oral diuretic in ambulatory cardiac patients.
    BRAVEMAN WS; DEXTER RL; RUBIN AL
    Am Heart J; 1957 Aug; 54(2):284-90. PubMed ID: 13444195
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experiences concerning the effect of strophanthin.
    FROST J; WARBURG E
    Acta Med Scand; 1948; 131(Suppl 206):132-44. PubMed ID: 18881130
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognostic strophanthin test].
    GOTTSEGEN G
    Orv Hetil; 1951 Mar; 92(13):413-5. PubMed ID: 13046848
    [No Abstract]   [Full Text] [Related]  

  • 36. [Polyclinical treatment of heart disease with cynosid liquidum].
    STORCH H
    Ther Ggw; 1952 Mar; 91(3):102-4. PubMed ID: 12984383
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experiences with the oral administration of strophanthin G].
    MANCINI D; CAPITAINE CACERES R
    Dia Med; 1960 Mar; 32():358-60. PubMed ID: 14420506
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nialamide in some dermatoses].
    MAGANA LOZANO M
    Rev Asoc Medica Mex; 1961 Aug; 41():385-9. PubMed ID: 14468219
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of peripheral ischemic disorders with Niamid].
    FABRE J; LINDHEIMER M; MICHEL B
    Chemotherapia (Basel); 1962; 4():78-101. PubMed ID: 13891220
    [No Abstract]   [Full Text] [Related]  

  • 40. Key position of catecholamines in functional and degenerative cardiovascular pathology.
    RAAB W
    Am J Cardiol; 1960 May; 5():571-8. PubMed ID: 14435598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.